Autologous cell transplantation for the treatment of damaged myocardium

Progress in Cardiovascular Diseases

Volumn 45, Issue 1, 2002, Pages 21-32

  Penn, Marc S ^a   Francis, Gary S ^a   Ellis, Stephen G ^a   Young, James B ^a   McCarthy, Patrick M ^a   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOTRANSPLANTATION; CELL REGENERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HUMAN; NONHUMAN; REVIEW; SAFETY; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR; TREATMENT OUTCOME;

EID: 0036319736     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2002.123466     Document Type: Article

References (46)

1. Myoblast transplantation for heart failure
2. Preliminary results of clinical trials of therapeutic angiogenesis achieved by the implantation of self bone marrow cells for ischemic heart disease
3. Differentiation and long-term survival of C 2C12 myoblast grafts in heart
4. Smooth muscle cell transplantation into myocardial scar tissue improves heart function
5. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
6. Bone marrow cells regenerate infarcted myocardium
7. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis
8. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium
9. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium
10. Cell transplantation for myocardial repair: An experimental approach
11. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation
12. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction
13. Cellular therapy reverses myocardial dysfunction
14. Factors affecting functional outcome after autologous skeletal myoblast transplantation
15. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction
16. Cardiomyocyte transplantation in a porcine myocardial infarction model
17. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction
18. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium
19. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?
20. Cellular cardiomyoplasty improves diastolic properties of injured heart
21. Skeletal myoblast transplantation for repair of myocardial necrosis
22. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction
23. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
24. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
25. Autologous transplantation of bone marrow cells improves damaged heart function
26. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
27. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
28. Cellular cardiomyoplasty with allogeneic mesenchymal stem cells results in improved cardiac performance in a swine model of myocardial infarction
29. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts
30. Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells
31. Evidence that human cardiac myocytes divide after myocardial infarction
32. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo
33. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
34. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
35. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study
36. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
37. Mobilized bone marrow cells repair the infarcted heart, improving function and survival
38. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury
39. The effect of neutrophil depletion on reperfusion arrhythmias during intracoronary thrombolysis using the leukocyte removal filter
40. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
41. Targeted deletion of matrix metalloproteinase- 9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
42. Myeloperoxidase plays a central role in ventricular remodeling following acute myocardial infarction
43. Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction
44. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function
45. Adult-derived stem cells from the liver become myocytes in the heart in vivo
46. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization